3Bar Biologics delivers a sustainable microbe inoculant system that helps farmers increase crop yield.
3Bar Biologics has raised $250K in total funding. The most recent round was Seed. The last funding was announced in November 2021.
3Bar Biologics's investors include S2G Investments, Village Capital, Rev1 Ventures, SVG Ventures, QCA Ventures.
3Bar Biologics is headquartered in Columbus, United States.
3Bar Biologics delivers a sustainable microbe inoculant system that helps farmers increase crop yield.
3Bar Biologics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"3Bar Biologics — Funding & Investors." VCBacked, November 9, 2021, https://www.vcbacked.co/company/3bar-biologics. Accessed August 13, 2026.
VCBacked. (2021). 3Bar Biologics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/3bar-biologics
{{cite web |title=3Bar Biologics — Funding & Investors |url=https://www.vcbacked.co/company/3bar-biologics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated